Keyphrases
Treatment Regimen
100%
Adjunctive Therapy
100%
Macular Edema
100%
Retinal Vein Occlusion
100%
Anti-VEGF Therapy
100%
Retinal Thickness
80%
Combination Treatment
40%
Laser Therapy
40%
Intravitreal
40%
Ozurdex
40%
Visual Acuity
20%
First Year
20%
Monotherapy
20%
Visual Outcome
20%
Combination Therapy
20%
Retrospective Analysis
20%
Fovea
20%
12-month Follow-up
20%
Laser Photocoagulation
20%
Ranibizumab
20%
Safety Data
20%
Anatomical Outcome
20%
Non-ischemic
20%
Treatment Protocol
20%
Baseline Visual Acuity
20%
Retreatment Rate
20%
Randomized Controlled Study
20%
Short-term Efficacy
20%
Perfused Retina
20%
Real-world Effectiveness
20%
Visual Acuity Improvement
20%
Intravitreal Steroids
20%
Treatment-naïve
20%
Single-agent Therapy
20%
Medicine and Dentistry
Macular Edema
100%
Vasculotropin
100%
Retina Vein Occlusion
100%
Adjuvant Therapy
100%
Visual Acuity
60%
Dexamethasone
40%
Low Level Laser Therapy
40%
Combination Therapy
20%
Monotherapy
20%
Laser Coagulation
20%
Ranibizumab
20%
Retreatment
20%
Branch Retinal Vein Occlusion
20%
Pharmacology, Toxicology and Pharmaceutical Science
Vasculotropin
100%
Macular Edema
100%
Retina Vein Occlusion
100%
Dexamethasone
40%
Monotherapy
20%
Combination Therapy
20%
Ranibizumab
20%
Branch Retinal Vein Occlusion
20%